Blog

Follow us for the latest trends, insights and
innovations in the pharmaceutical industry.
Blog cover for specification setting for chemical intermediates, 7 costly mistakes pharmaceutical buyers make when reviewing supplier specifications

7 Costly Mistakes to Avoid in Intermediate Specifications

This buyer's guide explains how specification limits are set, how to judge whether they are reasonable, and the seven costly mistakes buyers make when they ...
Read More →
Blog banner about payment terms for pharmaceutical intermediates, risk balance between buyer and supplier, T/T, L/C, D/P, D/A comparison and 7 common buyer mistakes

Payment Terms for Intermediates: 7 Buyer Mistakes to Avoid

This guide compares T/T, L/C, D/P and D/A for pharmaceutical intermediate purchases, with worked costs on a $60,000 order and the seven mistakes buyers make.
Read More →
Blog cover about impurity fate mapping for pharmaceutical intermediates, purge assessment and COA limitations, ICH M7 Option 4 pharmaceutical quality analysis graphic, professional dark‑blue‑grey tech background

Impurity Fate Mapping: 5 Documents Buyers Should Request

An impurity absent from a Certificate of Analysis is not necessarily absent from the process — it may simply have been purged downstream. This guide ...
Read More →
Dual Sourcing for API Intermediates buyer qualification checklist, pharmaceutical supply chain risk management for generic drug manufacturers

Dual Sourcing for API Intermediates: A Buyer’s Qualification Checklist

This checklist shows buyers how to qualify a second supplier in six steps — documentation, batch consistency, quality agreements, and activation triggers included.
Read More →
Scroll to Top

Contact us to Get the Best Product Solution